0
Original Research: SLEEP MEDICINE |

Daytime Cheyne-Stokes Respiration in Ambulatory Patients With Severe Congestive Heart Failure Is Associated With Increased Mortality*

Thomas Brack, MD, FCCP; Irene Thüer, MD; Christian F. Clarenbach, MD; Oliver Senn, MD; Georg Noll, MD; Erich W. Russi, MD, FCCP; Konrad E. Bloch, MD, FCCP
Author and Funding Information

*From Pulmonary (Drs. Brack, Thüer, Clarenbach, Senn, Russi, and Bloch) and Cardiology (Dr. Noll) Divisions, University Hospital Zurich, Zurich, Switzerland.

Correspondence to: Konrad E. Bloch, MD, FCCP, Division of Pulmonary Medicine, University Hospital, Rämistrasse 100, CH-8091 Zurich, Switzerland; e-mail: pneubloc@usz.unizh.ch



Chest. 2007;132(5):1463-1471. doi:10.1378/chest.07-0121
Text Size: A A A
Published online

Background: Cheyne-Stokes respiration (CSR) frequently occurs in patients with severe heart failure during sleep and may increase mortality. Daytime CSR supposedly poses an even greater risk, but its prevalence and prognostic importance remain elusive. Therefore, we investigated the circadian prevalence of CSR and its influence on survival in patients with heart failure.

Methods: In 60 consecutive ambulatory patients (mean age ± SE, 58.0 ± 1.5 years; 6 women) with stable severe heart failure (left ventricular ejection fraction, 26 ± 1%; New York Heart Association [NYHA] class, 2.6 ± 0.1), the breathing pattern was unobtrusively monitored during 24 h of usual activities with a portable respiratory inductive plethysmograph.

Results: During nights, 62% of patients had ≥ 15 periodic breathing cycles per hour; during days, the corresponding prevalence was 16%. CSR prevailed in 32 ± 3% of the night and in 10 ± 2% of the day, with peaks at 4:00 am, 2:00 pm, and 6:00 pm. Eighteen patients with CSR during ≥ 10% of the daytime lived shorter without heart transplantation than 42 patients with < 10% of daytime CSR (p < 0.05) during 836 ± 27 days of follow-up. CSR during ≥ 10% of the daytime was an independent predictor of mortality (hazard ratio, 3.8; 95% confidence interval, 1.1 to 12.7; p < 0.05) when controlling for age, sex, brain natriuretic peptide, left ventricular ejection fraction, and NYHA class.

Conclusions: CSR occurs in 62% of patients with severe heart failure at night and in 16% during the day. Since daytime CSR is associated with reduced survival, solely performing sleep studies may not allow to adequately assess prognosis and tailor treatment in patients with severe heart failure.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543